Variant report
Variant | esv2442723 |
---|---|
Chromosome Location | chr7:18352014-18353376 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:18338973..18341007-chr7:18351398..18353885,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78366740 | chr7:18352080-18352081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534061167 | chr7:18352088-18352089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562960586 | chr7:18352092-18352093 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188125406 | chr7:18352101-18352102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181324864 | chr7:18352112-18352113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560143302 | chr7:18352125-18352126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527327745 | chr7:18352153-18352154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549087047 | chr7:18352197-18352198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554071977 | chr7:18352229-18352230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs117243629 | chr7:18352242-18352243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186390673 | chr7:18352303-18352304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549916058 | chr7:18352326-18352327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12668703 | chr7:18352342-18352343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150712542 | chr7:18352372-18352373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs17418807 | chr7:18352376-18352377 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs551886957 | chr7:18352425-18352426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs137953300 | chr7:18352483-18352484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149536508 | chr7:18352485-18352486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555419810 | chr7:18352535-18352536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376543230 | chr7:18352547-18352548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144148678 | chr7:18352579-18352580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191697090 | chr7:18352620-18352621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556676584 | chr7:18352655-18352656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs181815480 | chr7:18352657-18352658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545711886 | chr7:18352730-18352731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563191914 | chr7:18352738-18352739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186452607 | chr7:18352753-18352754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113018098 | chr7:18352757-18352758 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542671482 | chr7:18352759-18352760 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs115226935 | chr7:18352765-18352766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531924259 | chr7:18352789-18352790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190914640 | chr7:18352878-18352879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200457621 | chr7:18352903-18352904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183102152 | chr7:18352936-18352937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548359843 | chr7:18352974-18352975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565665830 | chr7:18353018-18353019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143395311 | chr7:18353052-18353053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568346796 | chr7:18353132-18353133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548930085 | chr7:18353141-18353142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs527904864 | chr7:18353304-18353305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186710551 | chr7:18353350-18353351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Rubinstein-Taybi syndrome | 22470819 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Bladder cancer | 21909424 | CNVD |
Cancer | 21183584 | CNVD |
Autism | 20808228 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:18337000-18355200 | Weak transcription | Primary B cells from cord blood | blood |
2 | chr7:18339600-18355200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr7:18346400-18352200 | Weak transcription | Primary hematopoietic stem cells | blood |
4 | chr7:18346600-18353000 | Weak transcription | Fetal Heart | heart |
5 | chr7:18349200-18352800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
6 | chr7:18349200-18355000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
7 | chr7:18349200-18358600 | Weak transcription | Colon Smooth Muscle | Colon |
8 | chr7:18349800-18352200 | Weak transcription | Primary B cells from peripheral blood | blood |
9 | chr7:18351200-18353000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr7:18352000-18352400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr7:18352000-18352800 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
12 | chr7:18352200-18352600 | Enhancers | Primary hematopoietic stem cells | blood |
13 | chr7:18352200-18352800 | Enhancers | Primary B cells from peripheral blood | blood |
14 | chr7:18352400-18353000 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
15 | chr7:18352400-18353000 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
16 | chr7:18352400-18353000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr7:18352600-18359400 | Weak transcription | Primary hematopoietic stem cells | blood |
18 | chr7:18352800-18353600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
19 | chr7:18352800-18359600 | Weak transcription | Primary B cells from peripheral blood | blood |
20 | chr7:18353000-18357200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
21 | chr7:18353000-18358200 | Enhancers | Fetal Heart | heart |